Evidence map›Paper›PMID 18709386›Full record

ArticlePflugers Archiv : European journal of physiology2009

Expression and function of K(v)7 channels in murine myometrium throughout oestrous cycle.

Laura A McCallum, Iain A Greenwood, Rachel M Tribe

Abstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. KCommunications medicine · 2026
    Article
  2. Article
  3. Review
  4. KCNQ5 activation by tannins mediates vasorelaxant effects of barks used in Native American botanical medicine.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  5. Article
  6. Chemical modulation of Kv7 potassium channels.RSC medicinal chemistry · 2021
    Review
  7. Kv7 Channels and Excitability Disorders.Handbook of experimental pharmacology · 2021
    Article
  8. Review
  9. Detrusor Smooth Muscle KFrontiers in physiology · 2020
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. The KCNE Tango - How KCNE1 Interacts with Kv7.1.Frontiers in pharmacology · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Laura A McCallumKing's College London, St Thomas' Hospital Campus, UK. laura.mccallum@kcl.ac.uk
Iain A Greenwood
Rachel M Tribe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study represents an extensive characterisation of the expression and functional impact of KCNQ and KCNE accessory subunits in a murine uterus using a combination of quantitative reverse transcription polymerase chain reaction, Western blot analysis, patch clamp electrophysiology and isometric tension recording. The use of uterine tissue throughout the oestrous cycle provided a physiological model with which to assess hormonal regulation of these genes. Messenger ribonucleic acid for all KCNQ genes were detected throughout the oestrous cycle with the KCNQ1 message predominant. KCNE isoforms were detected at each stage of the cycle. KCNE4 was the most abundant (p < 0.0001), and KCNQ1, KCNQ5 and KCNE1 were up-regulated in metestrous (p < 0.0001). The K(v)7 channel inhibitor XE991 reduced outward K(+) currents and significantly increased spontaneous myometrial contractions (p < 0.05), whereas retigabine (K(v)7 activator) significantly relaxed uterine tissues (p < 0.001). These data are the first to characterise KCNQ and KCNE gene expression in a cell type outside of neurons and the cardiovascular system.

Indexed as

AnimalsAnthracenesCarbamatesChromansEstrous CycleFemaleKCNQ1 Potassium ChannelMiceMice, Inbred C57BLMyometriumPhenylenediaminesPotassium Channel BlockersPotassium Channels, Voltage-GatedSulfonamidesUterine Contraction10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy-2,2-dimethylchromaneAnthracenesCarbamatesChromansezogabineKcne1 protein, mouseKCNQ1 Potassium ChannelKcnq1 protein, mousePhenylenediaminesPotassium Channel BlockersPotassium Channels, Voltage-GatedSulfonamides

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.